Wednesday, July 8, 2026

biotech · Type 1 Diabetes · Coronavirus · SABS

SAB Biotherapeutics

SAB Biotherapeutics trial registry — 9 ClinicalTrials.gov studies with program phase, status, and indication context.

Gaithersburg, USA HQ
2016 Founded
39 Employees
Public company Type
SABS · NYSE Ticker
Company details
Status
Public
HQ
Gaithersburg, USA
Founded
2016
Employees
39
Programs
8
Drugs
10
Patents
1
Intelligence · Clinical Trials

SAB Biotherapeutics clinical trials

Registry index of 9 ClinicalTrials.gov studies linked to SAB Biotherapeutics programs — each row shows trial ID, program name, phase, status, and indication.

SAB Biotherapeutics trial registry — 9 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for SAB Biotherapeutics.

  1. SAB-142, SODIUM CHLORIDE — Phase 2

    Clinical update
  2. Single Ascending Dose of SAB-176 — Phase 1

    Clinical update
  3. bamlanivimab 7000mg — Phase 3

    Clinical update
  4. SAB-185 — Phase 1

    Clinical update
  5. SAB-176 — Phase 1

    Clinical update
  6. SAB-176 — Phase 2

    Clinical update
  7. High Dose SAB-142 — Phase 2

    Clinical update
  8. SAB-301 — Phase 1

    Clinical update

Trial registry

9 studies